Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 70 Neoplasm Metastasis 20 Rectal Neoplasms 19 Colonic Neoplasms 17 Neoplasms 11 Cholangiocarcinoma 7 Carcinoma, Non-Small-Cell Lung 7 Head and Neck Neoplasms 6 Esophageal Neoplasms 6 Breast Neoplasms 6 Carcinoma, Squamous Cell 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Lung Neoplasms 4 Colorectal Cancer Metastatic 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Prostatic Neoplasms 3 Inflammatory Breast Neoplasms 3 Carcinoma 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Fallopian Tube Neoplasms 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Serotonin Syndrome 1 Salivary Gland Malignancy 1

Interventions

Oxaliplatin 3 Cetuximab 3 Capecitabine 3 Irinotecan 2 trifluridine tipiracil drug combination 1 surufatinib 1 regorafenib 1 raltitrexed 1 plocabulin 1 nimotuzumab 1 irinotecan sucrosofate 1 endostar protein 1 durvalumab 1 defactinib 1 Panitumumab 1 N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzene-sulfonamide 1 Drug Therapy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Colorectal Cancer × Panitumumab × Clear all

NCT03311750 2021-06-07

A-REPEAT

Hellenic Cooperative Oncology Group

Phase 2 Terminated

Gastrointestinal

Advanced Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡